Interleukin-6 and rheumatic diseases (Q34160235)

31 July 2017

1 reference

1 May 2021

Interleukin-6 and rheumatic diseases (English)

1 reference

31 July 2017

1 reference

25 August 2020

1 reference

1 May 2021

Peter E Lipsky

1

1 reference

31 July 2017

publication date

28 July 2006

5 references

Arthritis Research and Therapy

31 July 2017

17 June 2019

20 November 2019

25 August 2020

1 May 2021

5 references

31 July 2017

17 June 2019

20 November 2019

25 August 2020

1 May 2021

8 Suppl 2

1 reference

31 July 2017

page(s)

S4

1 reference

Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Mediators of inflammation and acute phase response in the liver

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Interleukin 6 is required for the development of collagen-induced arthritis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Immune responses of IL-4, IL-5, IL-6 deficient mice.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Bone turnover in non-steroid treated rheumatoid arthritis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Enhanced production of interleukin-6 in mice with type II collagen-induced arthritis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Interleukin-6: an overview

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Anemia of inflammation: the cytokine-hepcidin link

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946778

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

28 October 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Technology evaluation: MRA, Chugai

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Soluble IL-6 Receptor Governs IL-6 Activity in Experimental Arthritis: Blockade of Arthritis Severity by Soluble Glycoprotein 130

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

The influence of recombinant human interleukin-6 on blood and immune parameters in middle-aged and old rhesus monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/16899108

12 December 2020

Identifiers

DOI

10.1186/AR1918

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference